TargetAdenylate cyclase type 10(Homo sapiens (Human))
Tri-Institutional Institutional Therapeutics Discovery Institute
Curated by ChEMBL
Tri-Institutional Institutional Therapeutics Discovery Institute
Curated by ChEMBL
Affinity DataIC50: 1nMAssay Description:Inhibition of human ADCY10 assessed as cAMP accumulation preincubated for 15 mins followed by substrate addition using alpha-32P labelled ATP as subs...More data for this Ligand-Target Pair
Affinity DataIC50: 1.14nMAssay Description:Inhibition of adenylyl cyclase activity in rat cortical membranesMore data for this Ligand-Target Pair
Affinity DataIC50: 1.40nMAssay Description:Inhibition of dopamine-sensitive rat brain adenylyl cyclase activity assessed as cAMP levelMore data for this Ligand-Target Pair
TargetAdenylate cyclase type 10(Rattus norvegicus)
Tri-Institutional Institutional Therapeutics Discovery Institute
Curated by ChEMBL
Tri-Institutional Institutional Therapeutics Discovery Institute
Curated by ChEMBL
Affinity DataIC50: 1.90nMAssay Description:Inhibition of rat ADCY10 overexpressed in rat 4-4 cells assessed as IBMX stimulated cAMP accumulation preincubated for 10 mins followed by IBMX stimu...More data for this Ligand-Target Pair
TargetAdenylate cyclase type 10(Homo sapiens (Human))
Tri-Institutional Institutional Therapeutics Discovery Institute
Curated by ChEMBL
Tri-Institutional Institutional Therapeutics Discovery Institute
Curated by ChEMBL
Affinity DataIC50: 2.10nMAssay Description:Inhibition of human ADCY10 assessed as cAMP accumulation preincubated for 15 mins followed by substrate addition using alpha-32P labelled ATP as subs...More data for this Ligand-Target Pair
TargetAdenylate cyclase type 10(Homo sapiens (Human))
Tri-Institutional Institutional Therapeutics Discovery Institute
Curated by ChEMBL
Tri-Institutional Institutional Therapeutics Discovery Institute
Curated by ChEMBL
Affinity DataIC50: 2.20nMAssay Description:Inhibition of human ADCY10 assessed as cAMP accumulation preincubated for 15 mins followed by substrate addition using alpha-32P labelled ATP as subs...More data for this Ligand-Target Pair
TargetAdenylate cyclase type 10(Homo sapiens (Human))
Tri-Institutional Institutional Therapeutics Discovery Institute
Curated by ChEMBL
Tri-Institutional Institutional Therapeutics Discovery Institute
Curated by ChEMBL
Affinity DataIC50: 2.40nMAssay Description:Inhibition of human ADCY10 assessed as cAMP accumulation preincubated for 15 mins followed by substrate addition using alpha-32P labelled ATP as subs...More data for this Ligand-Target Pair
TargetAdenylate cyclase type 10(Rattus norvegicus)
Tri-Institutional Institutional Therapeutics Discovery Institute
Curated by ChEMBL
Tri-Institutional Institutional Therapeutics Discovery Institute
Curated by ChEMBL
Affinity DataIC50: 2.5nMAssay Description:Inhibition of rat ADCY10 overexpressed in rat 4-4 cells assessed as IBMX stimulated cAMP accumulation preincubated for 10 mins followed by IBMX stimu...More data for this Ligand-Target Pair
TargetAdenylate cyclase type 10(Homo sapiens (Human))
Tri-Institutional Institutional Therapeutics Discovery Institute
Curated by ChEMBL
Tri-Institutional Institutional Therapeutics Discovery Institute
Curated by ChEMBL
Affinity DataIC50: 3.30nMAssay Description:Inhibition of human ADCY10 assessed as cAMP accumulation preincubated for 15 mins followed by substrate addition using alpha-32P labelled ATP as subs...More data for this Ligand-Target Pair
TargetAdenylate cyclase type 10(Homo sapiens (Human))
Tri-Institutional Institutional Therapeutics Discovery Institute
Curated by ChEMBL
Tri-Institutional Institutional Therapeutics Discovery Institute
Curated by ChEMBL
Affinity DataIC50: 3.30nMAssay Description:Inhibition of human ADCY10 assessed as cAMP accumulation preincubated for 15 mins followed by substrate addition using alpha-32P labelled ATP as subs...More data for this Ligand-Target Pair
TargetAdenylate cyclase type 10(Homo sapiens (Human))
Tri-Institutional Institutional Therapeutics Discovery Institute
Curated by ChEMBL
Tri-Institutional Institutional Therapeutics Discovery Institute
Curated by ChEMBL
Affinity DataIC50: 3.90nMAssay Description:Inhibition of human ADCY10 assessed as cAMP accumulation preincubated for 15 mins followed by substrate addition using alpha-32P labelled ATP as subs...More data for this Ligand-Target Pair
TargetAdenylate cyclase type 10(Homo sapiens (Human))
Tri-Institutional Institutional Therapeutics Discovery Institute
Curated by ChEMBL
Tri-Institutional Institutional Therapeutics Discovery Institute
Curated by ChEMBL
Affinity DataIC50: 4nMAssay Description:Inhibition of human ADCY10 assessed as cAMP accumulation preincubated for 15 mins followed by substrate addition using alpha-32P labelled ATP as subs...More data for this Ligand-Target Pair
Affinity DataIC50: 4.5nMAssay Description:Inhibition of dopamine-sensitive rat brain adenylyl cyclase activity assessed as cAMP levelMore data for this Ligand-Target Pair
TargetAdenylate cyclase type 10(Homo sapiens (Human))
Tri-Institutional Institutional Therapeutics Discovery Institute
Curated by ChEMBL
Tri-Institutional Institutional Therapeutics Discovery Institute
Curated by ChEMBL
Affinity DataIC50: 4.60nMAssay Description:Inhibition of human ADCY10 assessed as cAMP accumulation preincubated for 15 mins followed by substrate addition using alpha-32P labelled ATP as subs...More data for this Ligand-Target Pair
TargetAdenylate cyclase type 10(Homo sapiens (Human))
Tri-Institutional Institutional Therapeutics Discovery Institute
Curated by ChEMBL
Tri-Institutional Institutional Therapeutics Discovery Institute
Curated by ChEMBL
Affinity DataIC50: 5.5nMAssay Description:Inhibition of human ADCY10 assessed as cAMP accumulation preincubated for 15 mins followed by substrate addition using alpha-32P labelled ATP as subs...More data for this Ligand-Target Pair
TargetAdenylate cyclase type 10(Rattus norvegicus)
Tri-Institutional Institutional Therapeutics Discovery Institute
Curated by ChEMBL
Tri-Institutional Institutional Therapeutics Discovery Institute
Curated by ChEMBL
Affinity DataIC50: 5.5nMAssay Description:Inhibition of rat ADCY10 overexpressed in rat 4-4 cells assessed as IBMX stimulated cAMP accumulation preincubated for 10 mins followed by IBMX stimu...More data for this Ligand-Target Pair
TargetAdenylate cyclase type 10(Rattus norvegicus)
Tri-Institutional Institutional Therapeutics Discovery Institute
Curated by ChEMBL
Tri-Institutional Institutional Therapeutics Discovery Institute
Curated by ChEMBL
Affinity DataIC50: 5.5nMAssay Description:Inhibition of rat ADCY10 overexpressed in rat 4-4 cells assessed as IBMX stimulated cAMP accumulation preincubated for 10 mins followed by IBMX stimu...More data for this Ligand-Target Pair
TargetAdenylate cyclase type 10(Homo sapiens (Human))
Tri-Institutional Institutional Therapeutics Discovery Institute
Curated by ChEMBL
Tri-Institutional Institutional Therapeutics Discovery Institute
Curated by ChEMBL
Affinity DataIC50: 6.70nMAssay Description:Inhibition of human ADCY10 assessed as cAMP accumulation preincubated for 15 mins followed by substrate addition using alpha-32P labelled ATP as subs...More data for this Ligand-Target Pair
Affinity DataIC50: 7.20nMAssay Description:Antagonistic activity of the compound evaluated in adenylyl cyclase assayMore data for this Ligand-Target Pair
TargetAdenylate cyclase type 10(Homo sapiens (Human))
Tri-Institutional Institutional Therapeutics Discovery Institute
Curated by ChEMBL
Tri-Institutional Institutional Therapeutics Discovery Institute
Curated by ChEMBL
Affinity DataIC50: 7.80nMAssay Description:Inhibition of human ADCY10 assessed as cAMP accumulation preincubated for 15 mins followed by substrate addition using alpha-32P labelled ATP as subs...More data for this Ligand-Target Pair
TargetAdenylate cyclase type 10(Rattus norvegicus)
Tri-Institutional Institutional Therapeutics Discovery Institute
Curated by ChEMBL
Tri-Institutional Institutional Therapeutics Discovery Institute
Curated by ChEMBL
Affinity DataIC50: 11nMAssay Description:Inhibition of rat ADCY10 overexpressed in rat 4-4 cells assessed as IBMX stimulated cAMP accumulation preincubated for 10 mins followed by IBMX stimu...More data for this Ligand-Target Pair
TargetAdenylate cyclase type 10(Homo sapiens (Human))
Tri-Institutional Institutional Therapeutics Discovery Institute
Curated by ChEMBL
Tri-Institutional Institutional Therapeutics Discovery Institute
Curated by ChEMBL
Affinity DataIC50: 12nMAssay Description:Inhibition of human ADCY10 assessed as cAMP accumulation preincubated for 15 mins followed by substrate addition using alpha-32P labelled ATP as subs...More data for this Ligand-Target Pair
TargetAdenylate cyclase type 10(Rattus norvegicus)
Tri-Institutional Institutional Therapeutics Discovery Institute
Curated by ChEMBL
Tri-Institutional Institutional Therapeutics Discovery Institute
Curated by ChEMBL
Affinity DataIC50: 15nMAssay Description:Inhibition of rat ADCY10 overexpressed in rat 4-4 cells assessed as IBMX stimulated cAMP accumulation preincubated for 10 mins followed by IBMX stimu...More data for this Ligand-Target Pair
TargetAdenylate cyclase type 10(Rattus norvegicus)
Tri-Institutional Institutional Therapeutics Discovery Institute
Curated by ChEMBL
Tri-Institutional Institutional Therapeutics Discovery Institute
Curated by ChEMBL
Affinity DataIC50: 17nMAssay Description:Inhibition of rat ADCY10 overexpressed in rat 4-4 cells assessed as IBMX stimulated cAMP accumulation preincubated for 10 mins followed by IBMX stimu...More data for this Ligand-Target Pair
TargetAdenylate cyclase type 10(Homo sapiens (Human))
Tri-Institutional Institutional Therapeutics Discovery Institute
Curated by ChEMBL
Tri-Institutional Institutional Therapeutics Discovery Institute
Curated by ChEMBL
Affinity DataIC50: 17nMAssay Description:Inhibition of human ADCY10 assessed as cAMP accumulation preincubated for 15 mins followed by substrate addition using alpha-32P labelled ATP as subs...More data for this Ligand-Target Pair
TargetAdenylate cyclase type 10(Rattus norvegicus)
Tri-Institutional Institutional Therapeutics Discovery Institute
Curated by ChEMBL
Tri-Institutional Institutional Therapeutics Discovery Institute
Curated by ChEMBL
Affinity DataIC50: 20nMAssay Description:Inhibition of rat ADCY10 overexpressed in rat 4-4 cells assessed as IBMX stimulated cAMP accumulation preincubated for 10 mins followed by IBMX stimu...More data for this Ligand-Target Pair
Affinity DataIC50: 21nMAssay Description:Inhibition of [125 I]-6-IHPP-forskolin binding to adenylate cyclase 1More data for this Ligand-Target Pair
TargetAdenylate cyclase type 10(Homo sapiens (Human))
Tri-Institutional Institutional Therapeutics Discovery Institute
Curated by ChEMBL
Tri-Institutional Institutional Therapeutics Discovery Institute
Curated by ChEMBL
Affinity DataIC50: 21nMAssay Description:Inhibition of human ADCY10 assessed as cAMP accumulation preincubated for 15 mins followed by substrate addition using alpha-32P labelled ATP as subs...More data for this Ligand-Target Pair
TargetAdenylate cyclase type 10(Rattus norvegicus)
Tri-Institutional Institutional Therapeutics Discovery Institute
Curated by ChEMBL
Tri-Institutional Institutional Therapeutics Discovery Institute
Curated by ChEMBL
Affinity DataIC50: 23nMAssay Description:Inhibition of rat ADCY10 overexpressed in rat 4-4 cells assessed as IBMX stimulated cAMP accumulation preincubated for 10 mins followed by IBMX stimu...More data for this Ligand-Target Pair
TargetAdenylate cyclase type 10(Homo sapiens (Human))
Tri-Institutional Institutional Therapeutics Discovery Institute
Curated by ChEMBL
Tri-Institutional Institutional Therapeutics Discovery Institute
Curated by ChEMBL
Affinity DataIC50: 24nMAssay Description:Inhibition of human ADCY10 assessed as cAMP accumulation preincubated for 15 mins followed by substrate addition using alpha-32P labelled ATP as subs...More data for this Ligand-Target Pair
TargetAdenylate cyclase type 10(Homo sapiens (Human))
Tri-Institutional Institutional Therapeutics Discovery Institute
Curated by ChEMBL
Tri-Institutional Institutional Therapeutics Discovery Institute
Curated by ChEMBL
Affinity DataIC50: 28nMAssay Description:Inhibition of human soluble adenylyl cyclase assessed as reduction in cAMP levels in the presence of alpha-32p labeled ATP by biochemical assayMore data for this Ligand-Target Pair
Affinity DataIC50: 31nMAssay Description:Inhibition of [125 I]-6-IHPP-forskolin binding to adenylate cyclase 1More data for this Ligand-Target Pair
Affinity DataIC50: 32nMAssay Description:Inhibition of [125 I]-6-IHPP-forskolin binding to adenylate cyclase 1More data for this Ligand-Target Pair
TargetAdenylate cyclase type 10(Rattus norvegicus)
Tri-Institutional Institutional Therapeutics Discovery Institute
Curated by ChEMBL
Tri-Institutional Institutional Therapeutics Discovery Institute
Curated by ChEMBL
Affinity DataIC50: 35nMAssay Description:Inhibition of rat ADCY10 overexpressed in rat 4-4 cells assessed as IBMX stimulated cAMP accumulation preincubated for 10 mins followed by IBMX stimu...More data for this Ligand-Target Pair
Affinity DataIC50: 36nMAssay Description:Inhibition of [125 I]-6-IHPP-forskolin binding to adenylate cyclase 1More data for this Ligand-Target Pair
TargetAdenylate cyclase type 10(Rattus norvegicus)
Tri-Institutional Institutional Therapeutics Discovery Institute
Curated by ChEMBL
Tri-Institutional Institutional Therapeutics Discovery Institute
Curated by ChEMBL
Affinity DataIC50: 38nMAssay Description:Inhibition of rat ADCY10 overexpressed in rat 4-4 cells assessed as IBMX stimulated cAMP accumulation preincubated for 10 mins followed by IBMX stimu...More data for this Ligand-Target Pair
Affinity DataIC50: 39nMAssay Description:Inhibition of [125 I]-6-IHPP-forskolin binding to adenylate cyclase 1More data for this Ligand-Target Pair
Affinity DataIC50: 41nMAssay Description:Inhibition of [125 I]-6-IHPP-forskolin binding to adenylate cyclase 1More data for this Ligand-Target Pair
Affinity DataIC50: 43nMAssay Description:Inhibition of [125 I]-6-IHPP-forskolin binding to adenylate cyclase 1More data for this Ligand-Target Pair
Affinity DataIC50: 44nMAssay Description:Inhibition of [125 I]-6-IHPP-forskolin binding to adenylate cyclase 1More data for this Ligand-Target Pair
TargetAdenylate cyclase type 10(Homo sapiens (Human))
Tri-Institutional Institutional Therapeutics Discovery Institute
Curated by ChEMBL
Tri-Institutional Institutional Therapeutics Discovery Institute
Curated by ChEMBL
Affinity DataIC50: 64nMAssay Description:Inhibition of human ADCY10 assessed as cAMP accumulation preincubated for 15 mins followed by substrate addition using alpha-32P labelled ATP as subs...More data for this Ligand-Target Pair
Affinity DataIC50: 64nMAssay Description:Inhibition of [125 I]-6-IHPP-forskolin binding to adenylate cyclase 1More data for this Ligand-Target Pair
Affinity DataIC50: 65nMAssay Description:Inhibition of [125 I]-6-IHPP-forskolin binding to adenylate cyclase 1More data for this Ligand-Target Pair
TargetAdenylate cyclase type 10(Homo sapiens (Human))
Tri-Institutional Institutional Therapeutics Discovery Institute
Curated by ChEMBL
Tri-Institutional Institutional Therapeutics Discovery Institute
Curated by ChEMBL
Affinity DataIC50: 67nMAssay Description:Inhibition of human ADCY10 assessed as cAMP accumulation preincubated for 15 mins followed by substrate addition using alpha-32P labelled ATP as subs...More data for this Ligand-Target Pair
Affinity DataIC50: 73nMAssay Description:Inhibition of [125 I]-6-IHPP-forskolin binding to adenylate cyclase 1More data for this Ligand-Target Pair
TargetAdenylate cyclase type 10(Homo sapiens (Human))
Tri-Institutional Institutional Therapeutics Discovery Institute
Curated by ChEMBL
Tri-Institutional Institutional Therapeutics Discovery Institute
Curated by ChEMBL
Affinity DataIC50: 74nMAssay Description:Inhibition of human soluble adenylyl cyclase assessed as reduction in cAMP levels in the presence of alpha-32p labeled ATP by biochemical assayMore data for this Ligand-Target Pair
Affinity DataIC50: 76nMAssay Description:Inhibition of [125 I]-6-IHPP-forskolin binding to adenylate cyclase 1More data for this Ligand-Target Pair
Affinity DataIC50: 76nMAssay Description:Inhibition of [125 I]-6-IHPP-forskolin binding to adenylate cyclase 1More data for this Ligand-Target Pair
TargetAdenylate cyclase type 1/Adenylate cyclase type 2/Adenylate cyclase type 3/Adenylate cyclase type 4/Adenylate cyclase type 5/Adenylate cyclase type 6/Adenylate cyclase type 8/Adenylyl cyclase 7(Rattus norvegicus)
TBA
Curated by ChEMBL
TBA
Curated by ChEMBL
Affinity DataIC50: 80nMAssay Description:The compound was tested for adenylate cyclase activity in rat corpus striatumMore data for this Ligand-Target Pair
Affinity DataIC50: 82nMAssay Description:Inhibition of [125 I]-6-IHPP-forskolin binding to adenylate cyclase 1More data for this Ligand-Target Pair